Funding
This study was sponsored by Shandong Luoxin Pharmaceutical Group Co., Ltd., National Key Research and Development Program of China (No. 2018YFC1312101), and the Chinese Academy of Medical Science Innovation Fund for Medical Sciences(No. CIFMS-2021-I2M-1–014).